REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19-Reference-Cited by-同舟云学术

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

Published:2021-01-21 Issue:3 Volume:384 Page:238-251
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Weinreich David M.¹,Sivapalasingam Sumathi¹,Norton Thomas¹,Ali Shazia¹,Gao Haitao¹,Bhore Rafia¹,Musser Bret J.¹,Soo Yuhwen¹,Rofail Diana¹,Im Joseph¹,Perry Christina¹,Pan Cynthia¹,Hosain Romana¹,Mahmood Adnan¹,Davis John D.¹^ORCID,Turner Kenneth C.¹,Hooper Andrea T.¹,Hamilton Jennifer D.¹,Baum Alina¹,Kyratsous Christos A.¹,Kim Yunji¹,Cook Amanda¹,Kampman Wendy¹,Kohli Anita¹,Sachdeva Yessica¹,Graber Ximena¹,Kowal Bari¹,DiCioccio Thomas¹,Stahl Neil¹,Lipsich Leah¹,Braunstein Ned¹,Herman Gary¹,Yancopoulos George D.¹

Affiliation:

1. From Regeneron Pharmaceuticals, Tarrytown, NY (D.M.W., S.S., T.N., S.A., H.G., R.B., B.J.M., Y. Soo, D.R., J.I., C. Perry, C. Pan, R.H., A.M., J.D.D., K.C.T., A.T.H., J.D.H., A.B., C.A.K., Y.K., A.C., W.K., B.K., T.D., N.S., L.L., N.B., G.H., G.D.Y.); Arizona Liver Health, Tucson (A.K.), and Arizona Liver Health, Chandler (Y. Sachdeva); and AGA Clinical Trials, Hialeah, FL (X.G.).

Funder

U.S. Department of Health and Human Services

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2035002

Cited by 1428 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and immunological outcomes of SARS-CoV-2-infected vaccine responders, vaccine non-responders, and unvaccinated patients evaluated for neutralizing monoclonal antibody treatment at a single German tertiary care center: a retrospective cohort study with prospective follow-up;Infection;2024-02-02

2. Neutralization of SARS-CoV-2 and Intranasal Protection of Mice with a nanoCLAMP Antibody Mimetic;ACS Pharmacology & Translational Science;2024-02-01

3. Enhancing affinity purification of monoclonal antibodies from human serum for subsequent CZE-MS analysis;Journal of Chromatography B;2024-02

4. Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline: caution is warranted;eBioMedicine;2024-02

5. Exploring 2-methyl–substituted vitamin K3 derivatives with potent inhibitory activity against the 3CL protease of SARS-CoV-2;Bioorganic & Medicinal Chemistry Letters;2024-02